Ondansetron absorption in adults: effect of dosage form, food, and antacids. 1994

H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
Glaxo Inc., Research Triangle Park, NC 27709.

Ondansetron is a competitive serotonin 5-HT3 receptor blocker that has proved useful in the prevention of emesis due to cisplatin and other cancer chemotherapeutic agents. In a randomized, open-label, crossover study in 24 healthy male subjects, the relative bioavailability of a single 8-mg tablet was compared with that of an 8-mg solution using the two one-sided t-tests. The tablet and solution formulations were bioequivalent, as confirmed by similarities in mean Cmax (26.3 vs 27.7 ng/mL), Tmax (1.79 vs 1.70 h), and AUC (166.0 vs 167.3 ng.h/mL) values. In another randomized, open-label, crossover study in 12 healthy male subjects, the bioavailability of an 8-mg ondansetron tablet administered 5 min after a standard meal was slightly but significantly greater than in fasted subjects, as indicated by comparative mean AUC values [201.4 ng.h/mL (fed) vs 172.5 ng.h/mL (fasted)]. Coadministration of a magnesium hydroxide/aluminum hydroxide antacid did not affect the bioavailability of the ondansetron tablet.

UI MeSH Term Description Entries
D008297 Male Males
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000863 Antacids Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. Alkalinizing Agent,Antacid,Alkalinizing Agents,Agent, Alkalinizing,Agents, Alkalinizing

Related Publications

H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
November 1978, Clinical pharmacology and therapeutics,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
January 1991, European journal of drug metabolism and pharmacokinetics,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
September 1987, British journal of clinical pharmacology,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
October 1987, British journal of clinical pharmacology,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
May 1985, Deutsche medizinische Wochenschrift (1946),
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
November 1987, Chemical & pharmaceutical bulletin,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
July 2010, Journal of young pharmacists : JYP,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
August 2009, Pulmonary pharmacology & therapeutics,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
September 1977, Clinical pharmacology and therapeutics,
H P Bozigian, and J F Pritchard, and A E Gooding, and G E Pakes
October 1976, Lancet (London, England),
Copied contents to your clipboard!